首页> 外文OA文献 >835-5 Candesartan improves functional class across a broad spectrum of patients with chronic heart failure: Results of the candesartan in heart failure-assessment of reduction in mortality and morbidity programme (CHARM)

【2h】

835-5 Candesartan improves functional class across a broad spectrum of patients with chronic heart failure: Results of the candesartan in heart failure-assessment of reduction in mortality and morbidity programme (CHARM)

机译：835-5坎地沙坦改善了广泛范围的慢性心力衰竭患者的功能等级：坎地沙坦在心力衰竭中的结果-降低死亡率和发病率计划（CHARM）的评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
McMurray John J; Östergren Jan; Olofsson Bertil; Granger Christopher B; Michelson Eric; Young James B; Dunlap Mark; Yusuf Salim; Swedberg Karl; Pfeffer Marc A;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: Results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program [J] . CastagnoD., SkaliH., TakeuchiM., Journal of the American College of Cardiology . 2012,第20期

机译：广泛的慢性心力衰竭患者心率与预后的关联：CHARM（坎地沙坦治疗心衰：评估死亡率和发病率）计划的结果
2. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. [J] . Olsson LG, Swedberg K, Ducharme A, Journal of the American College of Cardiology . 2006,第10期

机译：伴或不伴左心室收缩功能不全的慢性心力衰竭的心房纤颤和临床事件风险：坎地沙坦心力衰竭-降低死亡率和发病率（CHARM）计划的评估结果。
3. Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. [J] . Omeara E, Lewis E, Granger C, European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2005,第4期

机译：病人对坎地沙坦治疗心力衰竭的效果的认识。坎地沙坦心力衰竭的结果：死亡率和发病率降低计划的评估。
4. Determinant role of short-term heart rate variability in the prediction of mortality in patients with chronic heart failure [C] . Pinna, G.D., Maestri, . 2000

机译：短期心率变异性在慢性心力衰竭患者死亡率预测中的决定性作用
5. Factors associated with adherence in heart failure. A secondary analysis of a large clinical trial: Candesartan in Heart failure -Assessment of Reduction in Mortality and Morbidity (CHARM) [D] . Granger, Bradi B. 2004

机译：与心力衰竭依从性相关的因素。大型临床试验的次要分析：坎地沙坦治疗心力衰竭-死亡率和发病率降低的评估（CHARM）
6. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program [O] . David Preiss, Sofia Zetterstrand, John J.V. McMurray, 2009

机译：坎地沙坦对心衰患者的死亡率和发病率降低（CHARM）程序进行评估时预测坎地沙坦对慢性心力衰竭患者糖尿病的发展趋势
7. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. [O] . McMurray, JJ, Ostergren, J, Pfeffer, MA, 2003

机译：低射血分数和保留射血分数低的心力衰竭患者的临床特征和当代管理：坎地沙坦心力衰竭患者的基线特征-死亡率和发病率降低评估（CHARM）计划。

835-5 Candesartan improves functional class across a broad spectrum of patients with chronic heart failure: Results of the candesartan in heart failure-assessment of reduction in mortality and morbidity programme (CHARM)

著录项

相似文献

相关主题

期刊订阅